檢索結果 - Dimple Modi
- Showing 1 - 4 results of 4
-
1
-
2
A phase 1 study of the pan‐bromodomain and extraterminal inhibitor mivebresib (ABBV‐075) alone or in combination with venetoclax in patients with relapsed/refractory acute myeloid... 由 Gautam Borthakur, Olatoyosi Odenike, Ibrahim Aldoss, David A. Rizzieri, Thomas Prébet, Christopher S. Chen, Relja Popovic, Dimple Modi, Rujuta Joshi, Johannes Wolff, Brian A. Jonas
出版 2021Artigo -
3
-
4
First-in-Human Study of Mivebresib (ABBV-075), an Oral Pan-Inhibitor of Bromodomain and Extra Terminal Proteins, in Patients with Relapsed/Refractory Solid Tumors 由 Sarina A. Piha‐Paul, Jasgit C. Sachdev, Minal Barve, Patricia LoRusso, Russell Z. Szmulewitz, Sapna P. Patel, Primo N. Lara, Xiaotian Chen, Beibei Hu, Kevin J. Freise, Dimple Modi, Anjla Sood, Jessica E. Hutti, Johannes Wolff, Bert H. O’Neil
出版 2019Artigo
相關主題
Cancer
Adverse effect
Biochemistry
Biology
Cancer research
Carcinogenesis
Dysgeusia
Gastroenterology
Gene
Genetics
Internal medicine
Medicine
Nausea
Oncology
Ovarian cancer
Anatomy
Astrobiology
Cell biology
Chronic lymphocytic leukemia
Computer science
Computer security
Endocrinology
Fallopian tube
Leukemia
Malignant transformation
Mutation
Myeloid leukemia
Neoplastic transformation
Ovary
PAX8